Olema Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on April 27, 2026, by Olema Pharmaceuticals, Inc. (OLMA). The filing discloses the entry into a material definitive agreement regarding the relocation of the Company's corporate headquarters.
Key Financial Metrics and Obligations
The filing details a new lease agreement with KR Oyster Point II, LLC for approximately 38,176 square feet of space. Key financial terms include:
- Total Base Rent (Phase I): $12,361,188.00 (net of rent abatement) over the initial term.
- Total Base Rent (Phase II): $6,145,463.76 (net of rent abatement) over the initial term.
- Cash Security Deposit: $427,546.80.
- Termination Fee: $1,716,240.96 (payable if the Company exercises its one-time option to terminate at the end of the 60th month).
- Initial Term: Seven years.
The filing does not provide current revenue, profit, cash flow, or debt figures, as this is a transactional report rather than a periodic financial statement.
Material Changes and Operational Impact
The Company intends to relocate its headquarters to the new premises by December 2026. This move coincides with the expiration of existing leases for office and lab space in San Francisco, which are scheduled to expire between December 2026 and January 2027. The new lease is structured in two phases:
- Phase I: 25,048 square feet on the fourth floor, expected to commence on or about September 15, 2026.
- Phase II: 13,128 square feet on the fifth floor, expected to commence on or about December 1, 2026.
The Landlord is responsible for all costs associated with pre-commencement work on the premises.
Outlook, Risks, and Contingencies
The agreement includes an option to extend the term for one additional five-year period and a right of first offer to expand into Suite 550 and the entire sixth floor. Risks associated with this agreement include the obligation to pay pro rata shares of operating expenses and taxes, as well as the potential for lease termination by the Landlord if the Company fails to remedy breaches of obligations within specified time periods.
Investor Verification Checklist
- Verify the total committed capital outlay for rent and security deposits against the Company's current cash position.
- Confirm the timeline for the relocation of corporate headquarters to ensure alignment with the expiration of current leases.
- Review the full text of the Lease agreement (to be filed in the Form 10-Q for the quarter ended March 31, 2026) for specific details on operating expense calculations and termination clauses.
- Assess the impact of the seven-year lease commitment on the Company's long-term liquidity and operational flexibility.